Diseases & Disorders
(G96C)
990 on File
AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY INC
Financial strength (30%)
94/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$4.0M
Total Revenue
$3.6M
Total Expenses
$25.5M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
84.9%
Fundraising Efficiency
N/A
Operating Reserve
85.55x
Liability-to-Asset
1.7%
Revenue Diversification
49.3%
Executive Compensation
$186K
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
84.9% | 83.2% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
15.1% | 11.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
85.6 mo | 12.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
1.7% | 12.5% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
49.3% | 87.6% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
0.5% | 7.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.1% | 5.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
11.7% | 4.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $4.0M | $3.6M | $25.5M | 84.9% | 0 |
| 2024 | $4.0M | $3.4M | $24.1M | 85.5% | 0 |
| 2023 | $3.8M | $3.2M | $20.3M | 84.6% | 0 |
| 2022 | $3.9M | $2.8M | $20.8M | 83.2% | 0 |
| 2021 | $3.0M | $1.4M | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.